These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 19246717)
1. Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension. Ferreira AJ; Shenoy V; Yamazato Y; Sriramula S; Francis J; Yuan L; Castellano RK; Ostrov DA; Oh SP; Katovich MJ; Raizada MK Am J Respir Crit Care Med; 2009 Jun; 179(11):1048-54. PubMed ID: 19246717 [TBL] [Abstract][Full Text] [Related]
2. The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Shenoy V; Ferreira AJ; Qi Y; Fraga-Silva RA; Díez-Freire C; Dooies A; Jun JY; Sriramula S; Mariappan N; Pourang D; Venugopal CS; Francis J; Reudelhuber T; Santos RA; Patel JM; Raizada MK; Katovich MJ Am J Respir Crit Care Med; 2010 Oct; 182(8):1065-72. PubMed ID: 20581171 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro. Haber PK; Ye M; Wysocki J; Maier C; Haque SK; Batlle D Hypertension; 2014 Apr; 63(4):774-82. PubMed ID: 24446061 [TBL] [Abstract][Full Text] [Related]
9. ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats. Li G; Liu Y; Zhu Y; Liu A; Xu Y; Li X; Li Z; Su J; Sun L Lung; 2013 Aug; 191(4):327-36. PubMed ID: 23652350 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme 2 activation protects against pulmonary arterial hypertension through improving early endothelial function and mediating cytokines levels. Li G; Xu YL; Ling F; Liu AJ; Wang D; Wang Q; Liu YL Chin Med J (Engl); 2012 Apr; 125(8):1381-8. PubMed ID: 22613639 [TBL] [Abstract][Full Text] [Related]
11. The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction. Chen IC; Lin JY; Liu YC; Chai CY; Yeh JL; Hsu JH; Wu BN; Dai ZK Int J Med Sci; 2020; 17(16):2594-2602. PubMed ID: 33029102 [TBL] [Abstract][Full Text] [Related]
13. Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia. Hampl V; Herget J; Bíbová J; Baňasová A; Husková Z; Vaňourková Z; Jíchová Š; Kujal P; Vernerová Z; Sadowski J; Červenka L Physiol Res; 2015; 64(1):25-38. PubMed ID: 25194138 [TBL] [Abstract][Full Text] [Related]
14. New targets in pulmonary hypertension--another ACE up the sleeve. Yin J; Kuebler WM Am J Respir Crit Care Med; 2009 Sep; 180(5):481-2; author reply 482. PubMed ID: 19700568 [No Abstract] [Full Text] [Related]
15. A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression. Haga S; Tsuchiya H; Hirai T; Hamano T; Mimori A; Ishizaka Y Exp Lung Res; 2015 Feb; 41(1):21-31. PubMed ID: 25275723 [TBL] [Abstract][Full Text] [Related]
16. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats. Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491 [TBL] [Abstract][Full Text] [Related]
17. Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: possible involvement of angiotensin-converting enzyme-2. Han SX; He GM; Wang T; Chen L; Ning YY; Luo F; An J; Yang T; Dong JJ; Liao ZL; Xu D; Wen FQ Toxicol Appl Pharmacol; 2010 May; 245(1):100-7. PubMed ID: 20178811 [TBL] [Abstract][Full Text] [Related]
18. Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat. Dang Z; Su S; Jin G; Nan X; Ma L; Li Z; Lu D; Ge R J Ethnopharmacol; 2020 Mar; 250():112470. PubMed ID: 31862407 [TBL] [Abstract][Full Text] [Related]
20. N-Acetyl-Seryl-Asparyl-Lysyl-Proline regulates lung renin angiotensin system to inhibit epithelial-mesenchymal transition in silicotic mice. Li S; Li Y; Zhang Y; Li S; Zhang M; Jin F; Wei Z; Yang Y; Gao X; Mao N; Ge X; Xu H; Yang F Toxicol Appl Pharmacol; 2020 Dec; 408():115255. PubMed ID: 33007385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]